Skip to main content
Have a personal or library account? Click to login
Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy Cover

Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy

Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
By: ,   and    
Open Access
|Oct 2023
Figures & tables

Figures & Tables

Figure 1:

Spatial and temporal aspects of intratumoral heterogeneity. The progression of the disease in the course of time culminates in cancer cells’ variation within and among primary and metastatic NSCLC.

Figure 2:

Schematic representation of intratumoral heterogeneity mechanisms and levels.

DOI: https://doi.org/10.2478/fco-2023-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 3 - 14
Submitted on: Jun 20, 2023
Accepted on: Jul 25, 2023
Published on: Oct 12, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Keywords:
Nonsmall-cell lung cancer,
NSCLC,
heterogeneity,
immunotherapy,
targeted treatment
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2023 A. Koulouris, C. Tsagkaris, G. Mountzios, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 13 (2022): Issue 3 (December 2022)
Previous article
Next article